Trial Profile
Safety and tolerability of dimethyl fumarate and fingolimod in subjects with relapsing-remitting multiple sclerosis (RRMS): Survey data from an online patient community (PatientsLikeMe)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 23 Feb 2016 New trial record